Parenteral Drug Association
FDANonrulemakingFDA-2014-D-1856

Guidance for Industry; Human Cells, Tissues, and Cellular and Tissue-Based Products from Adipose Tissue: Regulatory Considerations

RIN
Last modified
Apr 2, 2018
Comment window
closed 3591d ago
Parenteral Drug Association filings
1

Activity

Parenteral Drug Association filed 1 comment on this docket between Feb 23, 2015 and Feb 23, 2015. 0 other organizations filed here. The comment window closed 3591d ago.

What Parenteral Drug Association filed (1)

Feb 23, 2015· Comment from Parenteral Drug Association· FDA-2014-D-1856-0026

The Parenteral Drug Association congratulates FDA for preparing a clear guideline with the content presented in a logical and helpful fashion. The document is largely well written and the content of guideline is necessary to provide clarification to manufacturers working with adipose tissue. PDA recommends adding a couple of additional clarifications which are noted in the attachment.

Abstract

No abstract recorded.

View on regulations.gov →